Author(s)

R. Ramesh, N. AdhishwarKumaran, V. KuzhandaiVelu, R. Reeta, M. SathishBabu, G. Niranjan

Department of Biochemistry, MGMCRI, SBV University, Pilliyarkuppam, Pondicherry, India.

Bilirubin has both antioxidant activity and cardioprotective potential. Decreased levels are associated with predicting CAD. Recent studies showed that bilirubin has inverse correlation with glycemic status. So in this we evaluated the role of Hepatobiliary function as a marker of predictor CAD in patient with T2DM. Total 100 subjects included 50 T2DM patients with CAD and 50 T2DM without CAD. All the subject venous blood was collected after overnight fasting for biochemical analysis. After the statistical analysis, the results showed significant difference between two groups as follows total bilirubin (0.32 ± 0.15; 0.90 ± 032; p = 0.000), direct bilirubin, indirect bilirubibn, Total Protein, Albumin, ALT, AST, HbA1c. Our finding implies that decreased serum bilirubin increases the risk of CAD in patients with T2DM and it shows inverse correlation between HbA1c and bilirubin.

Bilirubin, Coronary Artery Disease, Type 2 Diabetes Mellitus

Ramesh, R. , AdhishwarKumaran, N. , KuzhandaiVelu, V. , Reeta, R. , SathishBabu, M. and Niranjan, G. (2015) Association between Hepato-Biliary Status and HbA1C in Type 2 Diabetes Mellitus with Coronary Artery Disease (CAD). Journal of Diabetes Mellitus, 5, 67-71. doi: 10.4236/jdm.2015.52008.